These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17849359)

  • 1. Substance P and its receptors -- a potential target for novel medicines in malignant brain tumour therapies (mini-review).
    Łazarczyk M; Matyja E; Lipkowski A
    Folia Neuropathol; 2007; 45(3):99-107. PubMed ID: 17849359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tachykinins and tachykinin receptors in bone.
    Goto T; Tanaka T
    Microsc Res Tech; 2002 Jul; 58(2):91-7. PubMed ID: 12203708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tachykinin receptors and receptor subtypes.
    Patacchini R; Maggi CA
    Arch Int Pharmacodyn Ther; 1995; 329(1):161-84. PubMed ID: 7639617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of tachykinins via NK1 receptors in progression of human gliomas.
    Palma C; Maggi CA
    Life Sci; 2000; 67(9):985-1001. PubMed ID: 10954033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tachykinins regulate the function of platelets.
    Graham GJ; Stevens JM; Page NM; Grant AD; Brain SD; Lowry PJ; Gibbins JM
    Blood; 2004 Aug; 104(4):1058-65. PubMed ID: 15130944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tachykinins and tachykinin receptors: structure and activity relationships.
    Almeida TA; Rojo J; Nieto PM; Pinto FM; Hernandez M; Martín JD; Candenas ML
    Curr Med Chem; 2004 Aug; 11(15):2045-81. PubMed ID: 15279567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat.
    Magraner J; Pinto FM; Anselmi E; Hernandez M; Perez-Afonso R; Martín JD; Advenier C; Candenas ML
    Br J Pharmacol; 1998 Jan; 123(2):259-68. PubMed ID: 9489614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.
    Patacchini R; Barthó L; Maggi CA
    Br J Pharmacol; 1997 Dec; 122(8):1633-8. PubMed ID: 9422808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tachykinins and their receptors in human malignancies.
    Palma C
    Curr Drug Targets; 2006 Aug; 7(8):1043-52. PubMed ID: 16918332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft.
    Palma C; Bigioni M; Irrissuto C; Nardelli F; Maggi CA; Manzini S
    Br J Cancer; 2000 Jan; 82(2):480-7. PubMed ID: 10646908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mammalian tachykinin receptors.
    Maggi CA
    Gen Pharmacol; 1995 Sep; 26(5):911-44. PubMed ID: 7557266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and molecular characterization of tachykinins and tachykinin receptors in the mouse uterus.
    Patak E; Pinto FM; Story ME; Pintado CO; Fleming A; Page NM; Pennefather JN; Candenas ML
    Biol Reprod; 2005 May; 72(5):1125-33. PubMed ID: 15647454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancing drug therapy for brain tumours: a current review of the pro-inflammatory peptide Substance P and its antagonists as anti-cancer agents.
    Mander K; Harford-Wright E; Lewis KM; Vink R
    Recent Pat CNS Drug Discov; 2014; 9(2):110-21. PubMed ID: 25386916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tachykinin NK1 receptor in the brain: pharmacology and putative functions.
    Saria A
    Eur J Pharmacol; 1999 Jun; 375(1-3):51-60. PubMed ID: 10443564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurokinin-receptor antagonists: pharmacological tools and therapeutic drugs.
    Longmore J; Hill RG; Hargreaves RJ
    Can J Physiol Pharmacol; 1997 Jun; 75(6):612-21. PubMed ID: 9276138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tachykinergic system as avenues for drug intervention.
    Rameshwar P
    Recent Pat CNS Drug Discov; 2012 Aug; 7(2):173-80. PubMed ID: 22472024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological characterisation of tachykinin receptors in the rat nucleus of the solitary tract and dorsal motor nucleus of the vagus in vitro.
    Maubach KA; Jones RS
    Br J Pharmacol; 1997 Nov; 122(6):1151-9. PubMed ID: 9401780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tachykinin antagonists and the airways.
    Joos GF; Kips JC; Peleman RA; Pauwels RA
    Arch Int Pharmacodyn Ther; 1995; 329(1):205-19. PubMed ID: 7543746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human.
    Lecci A; Capriati A; Altamura M; Maggi CA
    Auton Neurosci; 2006 Jun; 126-127():232-49. PubMed ID: 16616700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of possible therapies targeted for the tachykinergic system with the biology of neurokinin receptors and emerging related proteins.
    Rameshwar P
    Recent Pat CNS Drug Discov; 2007 Jan; 2(1):79-84. PubMed ID: 18221219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.